114
Participants
Start Date
March 31, 2009
Primary Completion Date
December 31, 2009
Study Completion Date
January 31, 2010
CR845
CR845 (0.024 mg/kg) administered the day after surgery (Day 1)
CR845
CR845 (0.008 mg/kg) administered the day after surgery (Day 1)
CR845
CR845 (0.040 mg/kg) administered immediately after surgery (Day 0)
Placebo
Matched placebo administered the day after surgery (Day 1)
Placebo
Matched placebo administered immediately after surgery (Day 0)
University of Miami/Jackson Memorial Hospital, Miami
Palms West Hospital, Loxahatchee Groves
Helen Keller Hospital, Sheffield
Mobile Infirmary Medical Center, Mobile
Springhill Medical Center, Mobile
The Ohio State University Medical Center, Columbus
Memorial Hermann - Memorial City Medical Center, Houston
The Woman's Hospital of Texas, Houston
Paradise Valley Hospital, Phoenix
Huntington Memorial Hospital, Pasadena
Adventist Medical Center, Glendale
Saddleback Memorial Hospital, Laguna Hills
Lead Sponsor
Cara Therapeutics, Inc.
INDUSTRY